FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891237103> ?p ?o ?g. }

• W2891237103 endingPage "642" @default.
• W2891237103 startingPage "632" @default.
• W2891237103 abstract "ObjectivesContrast enhanced ultrasound (CEUS) has been suggested as an imaging tool for detection of asymptomatic carotid atherosclerotic disease (ACAD) at high risk of cerebral embolisation. The objective of this study was to evaluate CEUS and immunohistochemical (IHC) patterns in ACAD (i.e., without any neurologic symptoms in the last 6 months) and their correlations with histology.MethodsCEUS analysis was classified on a semiquantitative basis using a three-point classification scale. Plaque morphology was assessed using the American Heart Association (AHA) classification of atherosclerotic plaques, then accordingly assigned as non-vulnerable (AHA Type IV/V) or vulnerable (AHA Type VI). IHC analysis for intra-plaque neo-angiogenesis (IPN) was identified by CD34/VEGF immunostaining and classified on a semiquantitative basis using a four-point classification scale. Both CEUS and IHC analyses were performed and scored by single observers.ResultsFifty-eight consecutive asymptomatic patients (mean age 73 years, 33 males) undergoing carotid endarterectomy were included in the final analysis. Nineteen had AHA Class IV/V plaques, and the remaining 39 had AHA Class VI plaques. There were two main findings of the study: (a) histologically proven vulnerable plaques compared with histologically proven non-vulnerable plaques had denser IPN (p = .004), but did not show more pronounced contrast enhancement; (b) the correlation between IHC analysis and CEUS analysis was significant for both vulnerable and non-vulnerable plaques (p = .04 and p = .01, respectively), but it was direct for AHA Type IV/V plaques and inverse for AHA Type VI plaques.ConclusionsThe main findings of the study were that histologically proven vulnerable plaques (i.e., AHA Class VI) as compared with histologically proven non-vulnerable plaques (i.e., AHA Class IV/V) had denser neo-vascularisation, but not more pronounced contrast enhancement. Contrast enhanced ultrasound (CEUS) has been suggested as an imaging tool for detection of asymptomatic carotid atherosclerotic disease (ACAD) at high risk of cerebral embolisation. The objective of this study was to evaluate CEUS and immunohistochemical (IHC) patterns in ACAD (i.e., without any neurologic symptoms in the last 6 months) and their correlations with histology. CEUS analysis was classified on a semiquantitative basis using a three-point classification scale. Plaque morphology was assessed using the American Heart Association (AHA) classification of atherosclerotic plaques, then accordingly assigned as non-vulnerable (AHA Type IV/V) or vulnerable (AHA Type VI). IHC analysis for intra-plaque neo-angiogenesis (IPN) was identified by CD34/VEGF immunostaining and classified on a semiquantitative basis using a four-point classification scale. Both CEUS and IHC analyses were performed and scored by single observers. Fifty-eight consecutive asymptomatic patients (mean age 73 years, 33 males) undergoing carotid endarterectomy were included in the final analysis. Nineteen had AHA Class IV/V plaques, and the remaining 39 had AHA Class VI plaques. There were two main findings of the study: (a) histologically proven vulnerable plaques compared with histologically proven non-vulnerable plaques had denser IPN (p = .004), but did not show more pronounced contrast enhancement; (b) the correlation between IHC analysis and CEUS analysis was significant for both vulnerable and non-vulnerable plaques (p = .04 and p = .01, respectively), but it was direct for AHA Type IV/V plaques and inverse for AHA Type VI plaques. The main findings of the study were that histologically proven vulnerable plaques (i.e., AHA Class VI) as compared with histologically proven non-vulnerable plaques (i.e., AHA Class IV/V) had denser neo-vascularisation, but not more pronounced contrast enhancement." @default.
• W2891237103 created "2018-09-27" @default.
• W2891237103 creator A5002297232 @default.
• W2891237103 creator A5009932796 @default.
• W2891237103 creator A5044812537 @default.
• W2891237103 creator A5047444976 @default.
• W2891237103 creator A5051020457 @default.
• W2891237103 creator A5057908952 @default.
• W2891237103 creator A5064751069 @default.
• W2891237103 creator A5089904179 @default.
• W2891237103 date "2018-11-01" @default.
• W2891237103 modified "2023-10-16" @default.
• W2891237103 title "Contrast Enhanced Ultrasound (CEUS) Is Not Able to Identify Vulnerable Plaques in Asymptomatic Carotid Atherosclerotic Disease" @default.
• W2891237103 cites W1565401187 @default.
• W2891237103 cites W1848861661 @default.
• W2891237103 cites W1905055296 @default.
• W2891237103 cites W1975476773 @default.
• W2891237103 cites W1981323571 @default.
• W2891237103 cites W1984508486 @default.
• W2891237103 cites W1989511609 @default.
• W2891237103 cites W1989854555 @default.
• W2891237103 cites W1997330245 @default.
• W2891237103 cites W2002131026 @default.
• W2891237103 cites W2002833753 @default.
• W2891237103 cites W2003287898 @default.
• W2891237103 cites W2037332106 @default.
• W2891237103 cites W2038822059 @default.
• W2891237103 cites W2054258901 @default.
• W2891237103 cites W2054544120 @default.
• W2891237103 cites W2055977153 @default.
• W2891237103 cites W2062437832 @default.
• W2891237103 cites W2072920954 @default.
• W2891237103 cites W2095314217 @default.
• W2891237103 cites W2095819288 @default.
• W2891237103 cites W2097028323 @default.
• W2891237103 cites W2100089051 @default.
• W2891237103 cites W2101559592 @default.
• W2891237103 cites W2101974951 @default.
• W2891237103 cites W2107259304 @default.
• W2891237103 cites W2114092046 @default.
• W2891237103 cites W2114235149 @default.
• W2891237103 cites W2117081885 @default.
• W2891237103 cites W2119852826 @default.
• W2891237103 cites W2124008781 @default.
• W2891237103 cites W2127027694 @default.
• W2891237103 cites W2130402106 @default.
• W2891237103 cites W2133858220 @default.
• W2891237103 cites W2140034531 @default.
• W2891237103 cites W2141470773 @default.
• W2891237103 cites W2144293114 @default.
• W2891237103 cites W2148083038 @default.
• W2891237103 cites W2149307753 @default.
• W2891237103 cites W2151749258 @default.
• W2891237103 cites W2156062467 @default.
• W2891237103 cites W2158318180 @default.
• W2891237103 cites W2159712796 @default.
• W2891237103 cites W2159767534 @default.
• W2891237103 cites W2164089346 @default.
• W2891237103 cites W2247997571 @default.
• W2891237103 cites W2273709812 @default.
• W2891237103 cites W2315608503 @default.
• W2891237103 cites W23687344 @default.
• W2891237103 cites W2511726655 @default.
• W2891237103 cites W2604547252 @default.
• W2891237103 cites W2604598110 @default.
• W2891237103 cites W2605484715 @default.
• W2891237103 cites W2612334191 @default.
• W2891237103 cites W2623223075 @default.
• W2891237103 cites W2745403241 @default.
• W2891237103 cites W2757178221 @default.
• W2891237103 cites W2763912116 @default.
• W2891237103 doi "https://doi.org/10.1016/j.ejvs.2018.07.024" @default.
• W2891237103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30193730" @default.
• W2891237103 hasPublicationYear "2018" @default.
• W2891237103 type Work @default.
• W2891237103 sameAs 2891237103 @default.
• W2891237103 citedByCount "15" @default.
• W2891237103 countsByYear W28912371032019 @default.
• W2891237103 countsByYear W28912371032020 @default.
• W2891237103 countsByYear W28912371032021 @default.
• W2891237103 countsByYear W28912371032022 @default.
• W2891237103 countsByYear W28912371032023 @default.
• W2891237103 crossrefType "journal-article" @default.
• W2891237103 hasAuthorship W2891237103A5002297232 @default.
• W2891237103 hasAuthorship W2891237103A5009932796 @default.
• W2891237103 hasAuthorship W2891237103A5044812537 @default.
• W2891237103 hasAuthorship W2891237103A5047444976 @default.
• W2891237103 hasAuthorship W2891237103A5051020457 @default.
• W2891237103 hasAuthorship W2891237103A5057908952 @default.
• W2891237103 hasAuthorship W2891237103A5064751069 @default.
• W2891237103 hasAuthorship W2891237103A5089904179 @default.
• W2891237103 hasBestOaLocation W28912371031 @default.
• W2891237103 hasConcept C126838900 @default.
• W2891237103 hasConcept C142724271 @default.
• W2891237103 hasConcept C143753070 @default.
• W2891237103 hasConcept C206111553 @default.
• W2891237103 hasConcept C2777910003 @default.
• W2891237103 hasConcept C2779585989 @default.

• next